𝔖 Bobbio Scriptorium
✦   LIBER   ✦

‘Tissue’ transglutaminase ablation reduces neuronal death and prolongs survival in a mouse model of Huntington's disease

✍ Scribed by Mastroberardino, P G; Iannicola, C; Nardacci, R; Bernassola, F; De Laurenzi, V; Melino, G; Moreno, S; Pavone, F; Oliverio, S; Fesus, L


Book ID
110016425
Publisher
Nature Publishing Group
Year
2002
Tongue
English
Weight
454 KB
Volume
9
Category
Article
ISSN
1350-9047

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Riluzole prolongs survival time and alte
✍ Johannes Schiefer; G. Bernhard Landwehrmeyer; Hans-Gerd Lüesse; Arne Sprünken; C 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 375 KB

Glutamate excitotoxicity has been suggested to contribute to the pathogenesis of Huntington's disease (HD). Riluzole is a substance with glutamate antagonistic properties that is used for neuroprotective treatment in amyotrophic lateral sclerosis and which is currently tested in clinical trials for

Mutant huntingtin and glycogen synthase
✍ Antonio Valencia; Patrick B. Reeves; Ellen Sapp; Xueyi Li; Jonathan Alexander; K 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 525 KB

## Abstract Patients with Huntington's disease have an expanded polyglutamine tract in huntingtin and suffer severe brain atrophy and neurodegeneration. Because membrane dysfunction can occur in Huntington's disease, we addressed whether mutant huntingtin in brain and primary neurons is present in